Biosimilar

Results: 639



#Item
1CONTACT: Media: Charlene McGrady, extMDS Pharma Services Scientist to Discuss Development of Biosimilar Monoclonal Antibodies at EGA Symposium

CONTACT: Media: Charlene McGrady, extMDS Pharma Services Scientist to Discuss Development of Biosimilar Monoclonal Antibodies at EGA Symposium

Add to Reading List

Source URL: www.mdsps.com

Language: English - Date: 2016-09-17 23:58:34
    2STATE BIOSIMILAR SUBSTITUTION LAWS Please note: This chart is for informational purposes only and does not constitute legal advice or opinions regarding any specific facts relating to the substitution of biosimilars. You

    STATE BIOSIMILAR SUBSTITUTION LAWS Please note: This chart is for informational purposes only and does not constitute legal advice or opinions regarding any specific facts relating to the substitution of biosimilars. You

    Add to Reading List

    Source URL: healthlawpolicymatters.mintzlevinblogs.com

    - Date: 2016-08-30 11:13:37
      3BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

      BIOLOGICS IN THE PRACTICE OF LAW LINDSAY KELLY* Biologics have come to occupy an increasingly important role in the medical industry, accounting for well over $200 billion in worldwide sales inNot surprisingly, bi

      Add to Reading List

      Source URL: www.harvard-jlpp.com

      Language: English
      427 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

      27 JANUARY 2016 BIOSIMILARS DEVELOPMENT - FROM PRE-CLINIC TO MARKET Several biological products, altogether worth over US$60 billion annual sales, are encountering patent expiry byThis opens up the opportunity for

      Add to Reading List

      Source URL: www.ideas-itn.eu

      Language: English - Date: 2016-02-01 06:18:00
      5January 8, 2016  BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

      January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

      Add to Reading List

      Source URL: www.dcat.org

      Language: English - Date: 2016-01-11 11:16:23
      6

      PDF Document

      Add to Reading List

      Source URL: www.dcat.org

      Language: English - Date: 2016-06-01 15:33:28
      7June 3, Medivation, Sanofi Move Closer to Showdown in Takeover Bid In response to a request by Sanofi, the biopharmaceutical company, Medivation, set a record date of June 1, 2016, for the 

      June 3, Medivation, Sanofi Move Closer to Showdown in Takeover Bid In response to a request by Sanofi, the biopharmaceutical company, Medivation, set a record date of June 1, 2016, for the 

      Add to Reading List

      Source URL: www.dcat.org

      Language: English - Date: 2016-06-06 08:58:55
      8ATTORNEY LISTINGS  Advisory Judicial Review (Dispute Litigation)

      ATTORNEY LISTINGS Advisory Judicial Review (Dispute Litigation)

      Add to Reading List

      Source URL: www.managingip.com

      Language: English - Date: 2015-09-23 06:20:50
      9Finland Life Science Stars Chart information represents survey responses by listed attorneys. Checkmarks were assigned by weighting respondents’ breakdown by their overall life sciences practice. NAME

      Finland Life Science Stars Chart information represents survey responses by listed attorneys. Checkmarks were assigned by weighting respondents’ breakdown by their overall life sciences practice. NAME

      Add to Reading List

      Source URL: www.managingip.com

      Language: English - Date: 2015-09-23 06:19:57
      10LIBRARY ACCESS Our industry reports utilize primary market research, which enables us to provide our customers novel data on topics that, until now, were only attainable through custom research. Our research categories i

      LIBRARY ACCESS Our industry reports utilize primary market research, which enables us to provide our customers novel data on topics that, until now, were only attainable through custom research. Our research categories i

      Add to Reading List

      Source URL: www.isrreports.com

      Language: English - Date: 2016-01-25 12:05:00